bpc 157 human clinical trials randomized Frontiers Regeneration or Risk? A Narrative
Description
Cancer history / active malignancy: compounds that promote angiogenesis and cell migration (BPC-157, TB-500) are generally treated as contraindicated where uncontrolled cell growth is a concern a standard caution across the recovery-peptide literature
Peptides are not on these standard panels
Are B12 shots the answer
PMID 11121126
Gut-brain communication in demyelinating disorders
